Determinants of insulin sensitivity and secretion in very-low-birth-weight children

Rodrigo A Bazaes1, Angélica Alegría, Enrica Pittaluga

  • 1Institute of Maternal and Child Research, Faculty of Medicine, University of Chile, Santiago 8360160, Chile.

Insights

In very-low-birth-weight (VLBW) children, both reduced fetal growth and rapid early weight gain impact insulin sensitivity and secretion. These findings highlight the importance of monitoring growth in VLBW infants for metabolic health.

Area of Science:

  • Endocrinology
  • Pediatric Metabolism
  • Neonatal Research

Background:

  • Low birth weight in children is linked to reduced insulin sensitivity, especially with rapid postnatal weight gain.
  • Associations between birth weight, growth patterns, and metabolic health in premature, very-low-birth-weight (VLBW) children require further investigation.

Purpose of the Study:

  • To investigate the relationship between birth weight, postnatal growth, and insulin sensitivity/secretion in VLBW prepubertal children.
  • To determine if being small for gestational age (SGA) affects insulin sensitivity in VLBW children.

Main Methods:

  • Studied 60 VLBW prepubertal children (aged 5-7 years) with varying birth weights and gestational ages.
  • Utilized a short intravenous glucose tolerance test to assess insulin sensitivity and secretion.
  • Employed analysis of covariance to evaluate the effects of body mass index, birth weight SD scores, postnatal growth rates, and morbidity.

Main Results:

  • Children born small for gestational age exhibited lower insulin sensitivity compared to those appropriate for gestational age.
  • Birth weight SD scores significantly correlated with insulin resistance, independent of current BMI and perinatal factors.
  • Early postnatal growth rates were significantly associated with insulin secretion, independent of birth weight SD scores.

Conclusions:

  • In VLBW children, both intrauterine growth (birth weight SD scores) and postnatal growth rates are independent determinants of insulin sensitivity and secretion.
  • These findings underscore the critical role of early growth trajectories in long-term metabolic programming for VLBW individuals.

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...